GW Taps Julie E. Bauman, MD, MPH, Renowned Cancer Clinician and Researcher, to Serve as Director of the GW Cancer Center
The renowned cancer clinician and researcher starts her new position in March 2022.
The renowned cancer clinician and researcher starts her new position in March 2022.
Vishal Patel, MD, director of the Cutaneous Oncology Program at the GW Cancer Center and the GW Medical Faculty Associates, breaks down what you need to know about skin cancer, how it is treated, and what you can do to protect yourself now.
Colorectal cancer is the third leading cause for cancer related deaths in the United States, and March is Colorectal Cancer Awareness Month. During this month, we are reminded that receiving regular cancer screening even while you have no signs or symptoms of disease in an important step in...
The ongoing corporate research partnership between SEAS Professor Michael Keidar and the biotech company US Patent Innovations, LLC employs engineering and translational molecular sciences to develop new medical devices
WASHINGTON (Aug. 5, 2020) — Genetic modifier HDAC6 was found to control tumor growth and halt metastasis in triple-negative breast cancer in vivo, according to a new study published in the top-tier journal Cancer Research by investigators at the George Washington University (GW) Cancer Center.
WASHINGTON (July 16, 2020) – The National Institutes of Health has awarded $3.6 million to ...
Experts at the George Washington University (GW) School of Medicine and Health Sciences are available to comment on stories around Breast Cancer Awareness Month. Experts are available to comment on “stage 0” breast cancer diagnosis, personalized medicine, survivorship, trends in breast cancer care and treatment, and more.
At the GW Cancer Center, we believe we have a responsibility to work toward health equity. Whether at the patient’s bedside or crunching data in a lab, connection with the communities we serve forms the foundation of everything we do.
That’s why we chose “re:connect” as the theme of this issue — it’s part of our mission to listen, understand, and address many of the problems that are unique to our region so that, ultimately, we see progress against cancer at a population level. Read Full Magazine